Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-27

Clinical Trial Update: Safety Study of Melatonin in Stroke Patients [Phase 4]

View source ↗

Summary

Phase 4 safety study evaluating melatonin in patients with acute ischemic stroke; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: Wolfson Medical Center | Conditions: Acute Ischemic Stroke | Phase 4 | Status: UNKNOWN